Menu

Category: General

Industry Insights Logo

Keeping the Lifeline Strong: Why 340B Matters More Than Ever for Safety-Net Hospitals and Other Providers

Sponsored Content Views
A Stablizing Force During an Uncertain Time

SPONSORED CONTENT

Across America, safety-net hospitals stand as a lifeline for millions. These institutions serve patients who often have nowhere else to turn — individuals who are uninsured, underinsured, or living in communities where healthcare access is limited.

For hospitals operating on razor-thin margins, the 340B

…
Read More »

News Alert

Trump Signs Executive Order to Impose ‘Most-Favored Nation’ Drug Pricing Model, Unlike April EO, 340B Implications Unclear

Shannon Young, Associate Editor/Senior Writer Views
President Donald Trump on Monday signed an executive order directing his administration Monday to establish a “most-favored nation” model for prescription drugs.
President Donald Trump directed his administration Monday to use its trade, regulatory and enforcement powers to establish a “most-favored nation” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Drug Industry Advocates Say 340B Providers Would be Unintended Beneficiaries in Effort to Kill Trump Proposed Medicaid Pricing Proposal

Shannon Young, Associate Editor/Senior Writer Views
A California think tank and drug industry advocates penned new op-eds warning against the possible 340B impacts of President Donald Trump's Medicaid drug pricing proposal.
A California think tank, and an influential drug industry trade group that funds it, are raising concerns that President Donald [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Hospital Group Warns that Medicare Drug Price Negotiation Payment Process Undermines 340B

Shannon Young, Associate Editor/Senior Writer Views
The American Hospital Association recently took issue with Biden administration IRA Medicare drug price negotiation guidance.
A key national hospital advocacy group recently urged the Trump administration to modify the retrospective payment process under the Inflation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Hawley, Welch Unveil Bipartisan Senate Bill to Lower Prescription Drug Prices

Shannon Young, Associate Editor/Senior Writer Views
U.S. Sens. Josh Hawley (R-Mo.) and Peter Welch (D-Vt.) announced the Fair Prescription Drug Prices for Americans Act on Monday.
A new bipartisan U.S. Senate proposal, backed by a key lawmaker involved in 340B policy, aims to lower the cost [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Trump’s FY 2026 Budget Blueprint Includes $33 Billion in HHS Cuts, No Details on 340B Plans

Shannon Young, Associate Editor/Senior Writer Views
The White House’s Discretionary Budget Request released Friday proposes nearly $94 billion in base discretionary HHS funding—a $33.3 billion cut.
President Donald Trump’s Fiscal Year 2026 budget blueprint released Friday calls for major cuts and shakeups at the U.S. Department [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

National HIV Group Voices Concerns Over Sen. Cassidy’s 340B Probe Findings, Reform Recommendations 

Shannon Young, Associate Editor/Senior Writer Views
Ryan White Clinics for 340B Access detailed its concerns with the legislative solutions Senate HELP Committee Chairman Bill Cassidy (R-La.) proposed in a recent report on the 340B program. 
A major national 340B provider advocacy group this week cautioned that proposed 340B reforms stemming from a high-profile GOP U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Sumitomo Exempts Four More States From 340B Contract Pharmacy Restrictions, GSK Exempts Nebraska, Utah

Shannon Young, Associate Editor/Senior Writer Views
Sumitomo Pharma America has announced exemptions to its contract pharmacy restrictions for 340B covered entities in Nebraska, North Dakota, South Dakota and Utah.
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

State 340B Contract Pharmacy Lawsuit Roundup: New Filings in Utah

William Newton, Associate Editor/Senior Writer Views
Key briefs were filed recently in state contract pharmacy litigation in Utah.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Former 340B Health, Evernorth Executives Join Walgreens 

Shannon Young, Associate Editor/Senior Writer Views
Greg Doggett and Ben Olson, two long-time executives in the 340B world, have recently taken on key positions at retail pharmacy giant Walgreens.
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live